M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
about
Protective immunity against tuberculosis: what does it look like and how do we find it?MicroRNA 27a-3p Regulates Antimicrobial Responses of Murine Macrophages Infected by Mycobacterium avium subspecies paratuberculosis by Targeting Interleukin-10 and TGF-β-Activated Protein Kinase 1 Binding Protein 2.Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.
P2860
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@en
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@nl
type
label
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@en
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@nl
prefLabel
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@en
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.
@nl
P2093
P2860
P356
P1433
P1476
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection
@en
P2093
A F Gembre
A R Piñeros
D M Fonseca
J C Alves-Filho
L W Campos
T B Bertolini
P2860
P2888
P356
10.1038/SREP41240
P407
P50
P577
2017-01-27T00:00:00Z